PR has received the following: consultancy and/or speaking fees (to his institution) from AbbVie, Abbott, Astellas, AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly, Gilead, Novo Nordisk and Sanofi-Aventis, and research grants from AstraZeneca, Bayer and Novo Nordisk
Neuron 23, 775786
Uncontrolled hypothyroidism may mask how much the GLP-1 medication is actually helping with weight loss, because thyroid-related water retention or metabolic slowdown might offset the drug's effects
Before any medication is considered, a provider reviews your health history, takes vitals, measures your body composition, and discusses whether a GLP-1 medication is appropriate for you
Application of high resolution fast atom bombardment and constant B/E ration linked scanning to the identification and analysis of acylcarnitines in metabolic disease
2020;105:dgz072